Polymyositis, dermatomyositis, and inclusion-body myositis

New England Journal of Medicine

Volumn 325, Issue 21, 1991, Pages 1487-1498

  Dalakas, Marinos C ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL INCLUSION; DERMATOMYOSITIS; HUMAN; MYOSITIS; PATHOLOGY; REVIEW; ULTRASTRUCTURE; CALCINOSIS; CLINICAL FEATURE; ELECTROMYOGRAPHY; IMMUNOPATHOLOGY; INTRAVENOUS DRUG ADMINISTRATION; MUSCLE BIOPSY; MUSCLE STRENGTH; ONSET AGE; PHYSIOTHERAPY; POLYMYOSITIS; PRIORITY JOURNAL; PROGNOSIS;

DERMATOMYOSITIS; HUMAN; INCLUSION BODIES; MYOSITIS;

ALUMINUM HYDROXIDE; AUTOANTIBODY; AZATHIOPRINE; COLCHICINE; CREATINE KINASE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; ETIDRONIC ACID; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; PREDNISONE; PROBENECID; WARFARIN;

EID: 0026429550     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM199111213252107     Document Type: Review

References (143)

1. Dalakas M.C., ed. Polymyositis and dermatomyositis. Boston: Butterworths, 1988
2. Carpenter S., Karpati G. The major inflammatory myopathies of unknown cause. Pathol Annu 1981; 16:205-37
3. Banker B.Q., Engel A.G. The polymyositis and dermatomyositis syndromes. In: Engel AG, Banker BQ, eds. Myology. New York: McGraw-Hill, 1986: 1385-422
4. Rowland L.P., ed. Merritt#x0027;s textbook of neurology. 8th ed. Philadelphia: Lea & Febiger, 1989: 733-8
5. Whitaker J.N. Inflammatory myopathy: a review of etiologic and pathogenetic factors. Muscle Nerve 1982; 5:573-92
6. Dalakas M.C. Inflammatory myopathies. Curr Opin Neurol Neurosurg 1990; 3:689-96
7. Plotz P.H., Dalakas M., Leff R.L., Love L.A., Miller F.W., Cronin M.E. Current concepts in the idiopathic inflammatory myopathies: polymyositis, dermatomyositis and related disorders. Ann Intem Med 1989:111:143-57
8. Karpati G., Carpenter S. Idiopathic inflammatory myopathies. Curr Opin Neurol Neurosurg 1988; 1:806-14
9. Ansell B.M., ed. Inflammatory diseases of muscle. Clin Rheum Dis 1984; 10:1-215
10. Mastaglia F.L., Ojeda V.J. Inflammatory myopathies: part 1. Ann Neurol 1985; 17:215-27
11. Engel A.G., Emslie-Smith A.M. Inflammatory myopathies. Curr Opin Neurol Neurosurg 1989; 2:695-700
12. Walton J. The idiopathic inflammatory myopathies and their treatment. J Neurol Neurosurg Psychiatry 1991; 54:285-7
13. Pearson C.M., Bohan A. The spectrum of polymyositis and dermatomyositis. Med Clin North Am 1977; 61:439-57
14. Bohan A., Peter J.B. Polymyositis and dermatomyositis. N Engl J Med 1975; 292:344-7, 403-7
15. Carpenter S., Karpati G., Heller I., Eisen A. Inclusion body myositis: a distinct variety of idiopathic inflammatory myopathy. Neurology 1978; 28:8-17
16. Medsger T.A., Dawson W.N., Masi A.T. The epidemiology of polymyositis. Am J Med 1979; 48:715-23
17. Franks A.G. Jr. Important cutaneous markers of dermatomyositis. J Musculoskeletal Med 1988; 5(9):39-63
18. Stahl N.I., Klippel J.H., Decker J.L. A cutaneous lesion associated with myositis. Ann Intern Med 1979; 91:577-9
19. Dalakas M.C. A classification of polymyositis and dermatomyositis. In: Dalakas MC, ed. Polymyositis and dermatomyositis. Boston: Butterworths, 1988: 1-16
20. Idem. Polymyositis and dermatomyositis: an overview. In: Dalakas MC, ed. Polymyositis and dermatomyositis. Boston: Butterworths, 1988: 327-36
21. Bunch T.W. Polymyositis: a case history approach to the differential diagnosis and treatment. Mayo Clin Proc 1990; 65:1480-97
22. Banker B.Q. Parasitic myositis and other inflammatory myopathies. In: Engel AG, Banker BQ, eds. Myology. New York: McGraw-Hill, 1986: 1467-524
23. Hertzman P.A., Blevins W.L., Mayer J., Greenfield B., Ting M., Gleich G.J. Association of the eosinophilia—myalgia syndrome with the ingestion of tryptophan. N Engl J Med 1990; 322:869-73
24. Shevell M., Rosenblatt B., Silver K., Carpenter S., Karpati G. Congenital inflammatory myopathy. Neurology 1990; 40:1111-4
25. Doyle D.R., McCurley T.L., Sergent J.S. Fatal polymyositis in D-penicillamine-treated rheumatoid arthritis. Ann Intern Med 1983; 98:327-30
26. Dalakas M.C., Illa I., Pezeshkpour G.H., Laukaitis J.P., Cohen B., Griffin J.L. Mitochondrial myopathy caused by long-term zidovudine therapy. N Engl J Med 1990; 322:1098-105
27. Mastaglia F.L. Adverse effects of drugs on muscle. Drugs 1982; 24:304-21
28. Engel W.K., Dalakas M.C. Treatment of neuromuscular diseases. In: Wiederhold WC, ed. Therapy for neurologic diseases. New York: John Wiley, 1982: 51-101
29. Shepherd J.J. Tropical myositis: is it an entity and what is its cause? Lancet 1983; 2:1240-2
30. Gaut P., Wong P.K., Myer R.D. Pyomyositis in a patient with the acquired immunodeficiency syndrome. Arch Intern Med 1988; 148:1608-10
31. Atlas E., Novak S.N., Duray P.H., Steere A.C., et al. Lyme myositis: muscle invasion by Borrelia burgdorferi. Ann Intern Med 1988; 109:245-6
32. Warner C.L., Fayad P.B., Heffner R.R. Jr. Legionella myositis. Neurology 1991; 41:750-2
33. Mikol J. Inclusion body myositis. In: Engel AG, Banker BQ, eds. Myology. New York: McGraw-Hill, 1986: 1423-38
34. Eisen A., Berry K., Gibson G. Inclusion body myositis: myopathy or neuropathy? Neurology 1983; 33:1109-14
35. Lotz B.P., Engel A.G., Nishino H., Stevens J.C., Litcy W.J. Inclusion body myositis. Brain 1989; 112:727-42
36. Cole A.J., Kuzniecky R., Karpati G., et al. Familial myopathy with changes resembling inclusion body myositis and periventricular leucoencephalopathy. Brain 1988; 111:1025-37
37. Massa R., Weiler B., Karpati G., Shoubridge E., Carpenter S. Familial inclusion body myositis among Kurdish-Iranian Jews. Arch Neurol 1991; 48: 519-22
38. Dietz F., Logeman J.A., Sahgal V., Schmid F.R. Cricopharyngeal muscle dysfunction in the differential diagnosis of dysphagia in polymyositis. Arthritis Rheum 1980; 23:491-5
39. DeMerieux P., Verity M.A., Clements P.J., Paulus H.E. Esophageal abnormalities and dysphagia in polymyositis and dermatomyositis: clinical, radiographic and pathologic features. Arthritis Rheum 1983; 26:961-8
40. Denbow C.E., Lie J.T., Tancredi R.G., Bunch T.W. Cardiac involvement in polymyositis: a clinicopathologic study of 20 autopsied patients. Arthritis Rheum 1979; 22:1088-92
41. Haupt H.M., Hutchins G.M. The heart and cardiac conduction system in polymyositis-dermatomyositis: a clinicopathologic study of 16 autopsied patients. Am J Cardiol 1982; 50:998-1006
42. Askari A.D. Cardiac abnormalities. Clin Rheum Dis 1984; 10:31-149
43. Tymms K.E., Webb J. Dermatopolymyositis and other connective tissue diseases: a review of 105 cases. J Rheumatol 1985; 12:1140-8
44. Hochberg M.C., Feldman D., Stevens M.B. Adult onset polymyositis/dermatomyositis: an analysis of clinical and laboratory features and survival in 76 patients with a review of the literature. Semin Arthritis Rheum 1986; 15: 168-78
45. Salmeron G., Greenberg S.D., Lidsky M.D. Polymyositis and diffuse interstitial lung disease: a review of the pulmonary histopathologic findings. Arch Intern Med 1981; 141:1005-10
46. Tazelaar H.D., Viggiano R.W., Pickersgill J., Colby T.V. Interstitial lung disease in polymyositis and dermatomyositis: clinical features and prognosis as correlated with histologic findings. Am Rev Respir Dis 1990; 141:727-33
47. Caro I. Dermatomyositis as a systemic disease. Med Clin North Am 1989; 73:1181-92
48. Lakhanpal S., Lie J.T., Conn D.L., et al. Pulmonary disease in polymyositis/ dermatomyositis: a clinicopathological analysis of 65 autopsy cases. Ann Rheum Dis 1987; 46:23-29
49. Bernstein R.M., Morgan S.H., Chapman J., et al. Anti-Jo-1 antibody: a marker for myositis with interstitial lung disease. BMJ 1984; 289:151-2
50. Barnes B.E. Dermatomyositis and malignancy: a review of the literature. Ann Intern Med 1976; 84:68-76
51. Callen J.P. Malignancy in polymyositis/dermatomyositis. Clin Dermatol 1988; 2:55-63
52. Manchul L.A., Jin A., Pritchard K.I., et al. The frequency of malignant neoplasms in patients with polymyositis-dermatomyositis: a controlled study. Arch Intern Med 1985; 145:1835-9
53. Lakhanpal S., Bunch T.W., Ilstrup D.M., Melton L.J. III. Polymyositis-dermatomyositis and malignant lesions: does an association exist? Mayo Clin Proc 1986; 61:645-53
54. Richardson J.B., Callen J.P. Dermatomyositis and malignancy. Med Clin North Am 1989; 73:1211-20
55. Callen J.P. The value of malignancy evaluation in patients with dermatomyositis. J Am Acad Dermatol 1982; 6:253-9
56. Mimori T. Scleroderma-polymyositis overlap syndrome: clinical and serologic aspects. Int J Dermatol 1987; 26:419-25
57. Bohan A., Peter J.B., Bowman R.L., Pearson C.M. Computer-assisted analysis of 153 patients with polymyositis and dermatomyositis. Medicine (Baltimore) 1977; 56:255-86
58. Rosenberg N.L., Carry M.R., Ringel S.P. Association of inflammatory myopathies with other connective tissue disorders and malignancies. In: Dalakas MC, ed. Polymyositis and dermatomyositis. Boston: Butterworths, 1988: 37-69
59. Sharp G.C. Mixed connective tissue disease. In: Wilson JD, Braunwald E, Isselbacher KJ, eds. Harrison#x0027;s principles of internal medicine. 12th ed. Vol. 2. New York: McGraw-Hill, 1991: 1448-9
60. Targoff I.N. Immunologic aspects of myositis. Curr Opin Rheumatol 1989; 1:432-42
61. Genth E., Mierau R., Genetzky P., et al. Immunogenetic associations of scleroderma-related antinuclear antibodies. Arthritis Rheum 1990; 33:657-65
62. Kagen L.J., Aram S. Creatine kinase activity inhibitor in sera from patients with muscle disease. Arthritis Rheum 1987; 30:213-7
63. Kagen L.J. Myoglobinemia in inflammatory myopathies. JAMA 1977; 237:1448-52
64. Barkhaus P.E., Nandedkar S.D., Sanders D.B. Quantitative EMG in inflammatory myopathy. Muscle Nerve 1990; 13:247-53
65. Uncini A., Lange D.J., Hayes A.P., et al. Long-duration polyphasic motor unit potentials in myopathies: a quantitative study with pathological correlation. Muscle Nerve 1990; 13:263-7
66. Robinson L.R. Polymyositis. Muscle Nerve 1991; 14:310-5
67. Carpenter S. Resin histology and electron microscopy in inflammatory myopathies. In: Dalakas MC, ed. Polymyositis and dermatomyositis. Boston: Butterworths, 1988: 195-215
68. Arahata K., Engel A.G. Monoclonal antibody analysis of mononuclear cells in myopathies. I: Quantitation of subsets according to diagnosis and sites of accumulation and demonstration and counts of muscle fibers invaded by T cells. Ann Neurol 1984; 16:193-208
69. Engel A.G., Arahata K. Mononuclear cells in myopathies: quantitation of functionally distinct subsets, recognition of antigen-specific cell-mediated cytotoxicity in some diseases and implications for the pathogenesis of the different inflammatory myopathies. Hum Pathol 1986; 17:704-21
70. Ringel S.P., Carry M.R., Aquilera A.J., Starcevich J.M. Quantitative histopathology of the inflammatory myopathies. Arch Neurol 1986; 43:1004-9
71. Whitaker J.N., Engel W.K. Vascular deposits of immunoglobulin and complement in idiopathic inflammatory myopathy. N Engl J Med 1972; 286: 333-8
72. Kissel J.T., Mendell J.R., Rammohan K.W. Microvascular deposition of complement membrane attack complex in dermatomyositis. N Engl J Med 1986; 314:329-34
73. Emslie-Smith A.M., Engel A.G. Microvascular changes in early and advanced dermatomyositis: a quantitative study. Ann Neurol 1990; 27:343-56
74. Kissel J.T., Halterman R.K., Rammohan K.W., Mendel J.R. The relationship of complement-mediated microvasculopathy to the histologic features and clinical duration of disease in dermatomyositis. Arch Neurol 1991; 48:26-30
75. Engel A.G., Arahata K. Monoclonal antibody analysis of mononuclear cells in myopathies. II. Phenotypes of autoinvasive cells in polymyositis and inclusion body myositis. Ann Neurol 1984; 16:209-15
76. Karpati G., Pouliot Y., Carpenter S. Expression of immunoreactive major histocompatibility complex products in human skeletal muscles. Ann Neurol 1988; 23:64-72
77. Arahata K., Engel A.G. Monoclonal antibody analysis of mononuclear cells in myopathies. V: Identification and quantitation of T8+ cytotoxic and T8+ suppressor cells. Ann Neurol 1988; 23:493-9
78. Emslie-Smith A.M., Arahata K., Engel A.G. Major histocompatibility complex class I antigen expression, immunolocalization of interferon subtypes and T-cell-mediated cytotoxicity in myopathies. Hum Pathol 1989; 20: 224-31
79. Hohlfeld R., Engel A.G. Coculture with autologous myotubes of cytotoxic T cells isolated from muscle in inflammatory myopathies. Ann Neurol 1991; 29:498-507
80. Hohlfeld R., Engel A.G., Ii K., Harper M.C. Polymyositis mediated by T lymphocytes that express the γ/δ receptor. N Engl J Med 1991; 324:877-81
81. Targoff I.N., Arnett F.C. Clinical manifestations in patients with antibody to PL-12 antigen (alanyl-tRNA synthetase). Am J Med 1990; 88:241-51
82. Targoff I.N. Immune mechanisms of myositis. Curr Opin Rheumatol 1990; 2:882-8
83. Mathews M.B., Bernstein R.M. Myositis autoantibody inhibits histidyl-tRNA synthetase: a model for autoimmunity. Nature 1983; 304:177-9
84. Mathews M.B., Reichlin M., Hughes G.R., Bernstein R.M. Anti-threonyl-tRNA synthetase, a second myositis-related autoantibody. J Exp Med 1984; 160:420-34
85. Bunn C.C., Bernstein R.M., Mathews M.B. Autoantibodies against alanyl-tRNA synthetase and tRNAA1a coexist and are associated with myositis. J Exp Med 1986; 163:1281-91
86. Amett F.C., Hirsch T.J., Bias W.B., Nishikai M., Reichlin M. The Jo-1 antibody system in myositis: relationships to clinical features and HLA. J Rheumatol 1981; 8:925-30
87. Hochberg M.C., Feldman D., Stevens M.B., Arnett F.C., Reichlin M. Antibody to Jo-1 in polymyositis/dermatomyositis: association with interstitial pulmonary disease. J Rheumatol 1984; 11:663-5
88. Targoff I.N., Arnett F.C., Berman L., O#x0027;Brien C., Reichlin M. Anti-KJ:a new antibody associated with the syndrome of polymyositis and interstitial lung disease. J Clin Invest 1989; 84:162-72
89. Arnett F.C. HLA genes and predisposition to rheumatic diseases. Hosp Pract [Off] 1986; 21(12):89-100
90. Ruff R.L. Acute viral myositis, virus-induced immune complex myositis and myoglobinuria. In: Vinken PJ, Bruyn GW, Klawans HL, McKendall RR, eds. Viral disease. Vol. 56 of Handbook of clinical neurology. Amsterdam: Elsevier Science, 1989: 193-206
91. Hays A.P., Gamboa E.T. Acute viral myositis. In: Engel AG, Banker BQ, eds. Myology. New York: McGraw-Hill, 1986: 1439-66
92. Denman A.M. Viral etiology of polymyositis/dermatomyositis. In: Dalakas MC, ed. Polymyositis and dermatomyositis. Boston: Butterworths, 1988: 97-120
93. Walker E.J., Jeffrey P.D. Sequence homology between encephalomyocarditis virus protein VPI and histidyl-tRNA synthetase supports a hypothesis of molecular mimicry in polymyositis. Med Hypotheses 1988; 25:21-26
94. Bowles N.E., Dubowitz V., Sewry C.A., Archard L.C. Dermatomyositis, polymyositis, and Coxsackie-B-virus infection. Lancet 1987; 1:1004-7
95. Rosenberg N.L., Rotbart H.A., Abzug M.J., Ringel S.P., Levin M.J. Evidence for a novel picornavirus in human dermatomyositis. Ann Neurol 1989; 26: 204-9
96. Yousef G.E., Isenberg D.A., Mowbray J.F. Detection of enterovirus specific RNA sequences in muscle biopsy specimens from patients with adult onset myositis. Ann Rheum Dis 1990; 49:310-5
97. Chou S.M. Inclusion body myositis: a chronic persistent mumps myositis. Hum Pathol 1986; 17:765-77
98. Nishino H., Engel A.G., Rima B.K. Inclusion body myositis: the mumps virus hypothesis. Ann Neurol 1989; 25:260-4
99. Dalakas M.C., London W.T., Gravell M., Sever J.L. Polymyositis in an immunodeficiency disease in monkeys induced by a type D retrovirus. Neurology 1986; 36:569-72
100. Dalakas M.C., Gravell M., London W.T., Cunningham G., Sever J.L. Morphological changes of an inflammatory myopathy in rhesus monkeys with simian acquired immunodeficiency syndrome. Proc Soc Exp Biol Med 1987; 185:368-76
101. Dalakas M.C., Pezeshkpour G.H., Gravell M., Sever J.L. Polymyositis in patients with AIDS. JAMA 1986; 256:2381-3
102. Dalakas M.C., Pezeshkpour G.H. Neuromuscular diseases associated with human immunodeficiency virus infection. Ann Neurol 1988; 23:Suppl: S38-S48
103. Dalakas M., Illa I. HIV-associated myopathies. In: Pizzo A, Wilfelt CM, eds. Pediatric AIDS. Baltimore: Williams & Wilkins, 1991: 420-9
104. Simpson D.M., Bender A.N. Human immunodeficiency virus-associated myopathy: analysis of 11 patients. Ann Neurol 1988; 24:79-84
105. Illa I., Nath A., Dalakas M.C. Immunocytochemical and virological characteristics of HIV-associated inflammatory myopathies: similarities with seronegative polymyositis. Ann Neurol 1991; 29:474-81
106. Lamperth L., Illa I., Dalakas M. In situ hybridization in muscle biopsies from patients with HIV-associated polymyositis (HIV-PM) using labeled HIV-RNA probes. Neurology 1990; 40:Suppl 1:121. abstract
107. Leon-Monzon M.E.L., Dalakas M. Detection of HIV in muscle and nerve biopsies by DNA-amplification techniques. Neurology 1991; 41:Suppl 1: 376. abstract
108. Lamperth L., Vicenzi E., Dalakas M. Infection and transfection of human muscle by HIV or HIV proviral-DNA construct. Neurology 1991; 41: Suppl 1:211. abstract
109. Morgan O., Rodgers-Johnson P., Mora C., Char G. HTLV-I and polymyositis in Jamaica. Lancet 1989; 2:1184-7
110. Wiley C.A., Nerenberg M., Cros D., Soto-Aguilar M.C. HTLV-I polymyositis in a patient also infected with the human immunodeficiency virus. N Engl J Med 1989; 320:992-5
111. Rucheton M., Graafland H., Fanton H., Ursule L., Ferrier P., Larsen C.J. Presence of circulating antibodies against gag-gene MuLV proteins in patients with autoimmune connective tissue disorders. Virology 1985; 144: 468-80
112. Arnaudo E., Dalakas M., Shanske S., Moraes C.R., DiMauro S., Schon E.A. Depletion of muscle mitochondrial DNA in AIDS patients with zidovudine-induced myopathy. Lancet 1991; 337:508-10
113. Dalakas M., Lamperth L., Dagani F. Abnormal muscle mitochondria induced by AZT in vitro and in an animal model: morphological, enzymatic and oxygen-consumption studies. Neurology 1991; 41:Suppl 1:375. abstract
114. Henriksson K.G., Sandstedt P. Polymyositis — treatment and prognosis: a study of 107 patients. Acta Neurol Scand 1982; 65:280-300
115. Uchino M., Araki S., Yoshida O., Uekawa K., Nagata J. High single-dose alternate-day corticosteroid regimens in treatment of polymyositis. J Neurol 1985; 232:175-8
116. Dalakas M.C. Treatment of polymyositis and dermatomyositis with corticosteroids: a first therapeutic approach. In: Dalakas MC, ed. Polymyositis and dermatomyositis. Boston: Butterworths, 1988: 235-53
117. Idem. Treatment of polymyositis and dermatomyositis. Curr Opin Rheumatol 1989; 1:443-9
118. Idem. Pharmacologic concerns of corticosteroids in the treatment of patients with immune-related neuromuscular diseases. Neurol Clin 1990; 8: 93-118
119. Oddis C.V., Medsger T.A. Relationship between serum creatine kinase level and corticosteroid therapy in polymyositis/dermatomyositis. J Rheumatol 1988; 15:807-11
120. Bunch T.W., Worthington J.W., Combs J.J., Duane M., Ilstrup M.S., Engel A.G. Azathioprine with prednisone for polymyositis: a controlled, clinical trial. Ann Intern Med 1980; 92:365-9
121. Bunch T.W. Prednisone and azathioprine for polymyositis: long-term follow-up. Arthritis Rheum 1981; 24:45-48
122. Metzger A.L., Bohan A., Goldberg L.S., Bluestone R., Pearson C.M. Polymyositis and dermatomyositis: combined methotrexate and corticosteroid therapy. Ann Intern Med 1974; 81:182-9
123. Niakan E., Pitner S.E., Whitaker J.N., Bertorini T.E. Immunosuppressive agents in corticosteroid-refractory childhood dermatomyositis. Neurology 1980; 30:286-91
124. Wallace D.J., Metzger A.L., White K.K. Combination immunosuppressive treatment of steroid-resistant dermatomyositis/polymyositis. Arthritis Rheum 1985; 28:590-2
125. Bunch T.W. The therapy of polymyositis. Mt Sinai J Med 1988; 55:483-6
126. Bombardieri S., Hughes G.R.V., Neri R., Del Bravo P., Del Bono L. Cyclophosphamide in severe polymyositis. Lancet 1989; 1:1138-9
127. Cronin M.E., Miller F.W., Hicks J.E., Dalakas M., Plotz P.H. The failure of intravenous cyclophosphamide therapy in refractory idiopathic inflammatory myopathy. J Rheumatol 1989; 16:1225-8
128. Heckmatt J., Hasson N., Saunders C., et al. Cyclosporin in juvenile dermatomyositis. Lancet 1989; 1:1063-6
129. Dau P.C. Plasmapheresis in idiopathic inflammatory myopathy: experience with 35 patients. Arch Neurol 1981; 38:544-52
130. Jones D.W., Snaith M.L., Isenberg D.A. Cyclosporine treatment for intractable polymyositis. Arthritis Rheum 1987; 30:959-60
131. Engel W.K., Lichter A.S., Galdi A.P. Polymyositis: remarkable response to total body irradiation. Lancet 1981; 1:658
132. Hubbard W.N., Walport M.J., Hainan K.E., Beaney R.P., Hughes G.R.V. Remission from polymyositis after total body irradiation. BMJ 1982; 284: 1915-6
133. Kelly J.J., Madoc-Jones H., Adelman L.S., Andres P.L., Munsat T.L. Response to total body irradiation in dermatomyositis. Muscle Nerve 1988; 11:120-3
134. Dalakas M.C., Engel W.K. Total body irradiation in the treatment of intractable polymyositis/dermatomyositis. In: Dalakas MC, ed. Polymyositis and dermatomyositis. Boston: Butterworths, 1988: 281-91
135. Kelly J.J. Jr., Madoc-Jones H., Adelman L.S., Andres P.L., Munsat T.L. Total body irradiation not effective in inclusion body myositis. Neurology 1986; 36:1264-6
136. Jan S., Beretta S., Maggio M., Alobbati L., Pellegrini G. High-dose intravenous human immunoglobulin in treatment-resistant polymyositis. Neurology 1990; 40:Suppl 1:120. abstract
137. Roifman C.M., Schaffer F.M., Wachsmuth S.E., Murphy G., Gelfand E.W. Reversal of chronic polymyositis following intravenous immune serum globulin therapy. JAMA 1987; 258:513-5
138. Cherin P., Herson S., Wechsler B., et al. Intravenous immunoglobulin for polymyositis and dermatomyositis. Lancet 1990; 336:116
139. Rowland L.P., Clark C., Olartc M. Therapy for dermatomyositis and polymyositis. Adv Neurol 1977; 17:63-97
140. al-Janadi M., Smith C.D., Karsh J. Cyclophosphamide treatment of interstitial pulmonary fibrosis in polymyositis/dermatomyositis. J Rheumatol 1989; 16:1592-6
141. Munsat T.L., Piper D., Cancilla P., Mednick J. Inflammatory myopathy with facioscapulohumeral distribution. Neurology 1972; 22:335-47
142. Wulff J.D., Lin J.T., Kepes J.J. Inflammatory facioscapulohumeral muscular dystrophy and Coats syndrome. Ann Neurol 1982; 12:398-401
143. Hudgson P., Fulthorpe J.J. The pathology of type II skeletal muscle glycogenosis: a light and electron-microscopic study. J Pathol 1975; 116:139-47